Lymphadenopathy after the third Covid-19 vaccine

Can Özütemiz; David A. Potter; Ayça Özbek Özütemiz; Daniel Steinberger

doi:10.1016/j.cpccr.2021.100127

Lymphadenopathy after the third Covid-19 vaccine

Can Özütemiz
, David A. Potter
, Ayça Özbek Özütemiz
, Daniel Steinberger

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Axillary lymphadenopathy ipsilateral to the vaccination site has been clinically and radiologically reported after administration of COVID-19 vaccines. This can be an important diagnostic dilemma, particularly in cancer patients who are being staged or re-staged, as this benign entity may mimic metastasis, cause unnecessary biopsies and changes in therapy. Here we present a breast cancer patient and a patient with squamous cell carcinoma of the head and neck, who had already received the first two doses of mRNA type COVID-19 vaccines before, now presenting with new hypermetabolic reactive lymphadenopathy on FDG PET/CT after the third booster dose.

Original language	English (US)
Article number	100127
Journal	Current Problems in Cancer: Case Reports
Volume	4
DOIs	https://doi.org/10.1016/j.cpccr.2021.100127
State	Published - Dec 2021

Bibliographical note

Funding Information:
Se hace extensivo un especial agradecimiento a los pacientes y a sus familiares que han participado en este estudio, a los m?dicos de otras instituciones quienes derivan pacientes a nuestra Instituci?n y a todos los profesionales y t?cnicos del Hospital Garrahan.

Publisher Copyright:
© 2021 The Author(s)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Covid 19
booster
lymphadenopathy
mRNA
vaccination
vaccine

Publisher link

10.1016/j.cpccr.2021.100127

Find It

Find It at U of M Libraries

Cite this

@article{8eccc79b2fcd4634818f767c86930bba,

title = "Lymphadenopathy after the third Covid-19 vaccine",

abstract = "Axillary lymphadenopathy ipsilateral to the vaccination site has been clinically and radiologically reported after administration of COVID-19 vaccines. This can be an important diagnostic dilemma, particularly in cancer patients who are being staged or re-staged, as this benign entity may mimic metastasis, cause unnecessary biopsies and changes in therapy. Here we present a breast cancer patient and a patient with squamous cell carcinoma of the head and neck, who had already received the first two doses of mRNA type COVID-19 vaccines before, now presenting with new hypermetabolic reactive lymphadenopathy on FDG PET/CT after the third booster dose.",

keywords = "Covid 19, booster, lymphadenopathy, mRNA, vaccination, vaccine",

author = "Can {\"O}z{\"u}temiz and Potter, \{David A.\} and {\"O}z{\"u}temiz, \{Ay{\c c}a {\"O}zbek\} and Daniel Steinberger",

note = "Funding Information: Se hace extensivo un especial agradecimiento a los pacientes y a sus familiares que han participado en este estudio, a los m?dicos de otras instituciones quienes derivan pacientes a nuestra Instituci?n y a todos los profesionales y t?cnicos del Hospital Garrahan. Publisher Copyright: {\textcopyright} 2021 The Author(s)",

year = "2021",

month = dec,

doi = "10.1016/j.cpccr.2021.100127",

language = "English (US)",

volume = "4",

journal = "Current Problems in Cancer: Case Reports",

issn = "2666-6219",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Lymphadenopathy after the third Covid-19 vaccine

AU - Özütemiz, Can

AU - Potter, David A.

AU - Özütemiz, Ayça Özbek

AU - Steinberger, Daniel

N1 - Funding Information: Se hace extensivo un especial agradecimiento a los pacientes y a sus familiares que han participado en este estudio, a los m?dicos de otras instituciones quienes derivan pacientes a nuestra Instituci?n y a todos los profesionales y t?cnicos del Hospital Garrahan. Publisher Copyright: © 2021 The Author(s)

PY - 2021/12

Y1 - 2021/12

N2 - Axillary lymphadenopathy ipsilateral to the vaccination site has been clinically and radiologically reported after administration of COVID-19 vaccines. This can be an important diagnostic dilemma, particularly in cancer patients who are being staged or re-staged, as this benign entity may mimic metastasis, cause unnecessary biopsies and changes in therapy. Here we present a breast cancer patient and a patient with squamous cell carcinoma of the head and neck, who had already received the first two doses of mRNA type COVID-19 vaccines before, now presenting with new hypermetabolic reactive lymphadenopathy on FDG PET/CT after the third booster dose.

AB - Axillary lymphadenopathy ipsilateral to the vaccination site has been clinically and radiologically reported after administration of COVID-19 vaccines. This can be an important diagnostic dilemma, particularly in cancer patients who are being staged or re-staged, as this benign entity may mimic metastasis, cause unnecessary biopsies and changes in therapy. Here we present a breast cancer patient and a patient with squamous cell carcinoma of the head and neck, who had already received the first two doses of mRNA type COVID-19 vaccines before, now presenting with new hypermetabolic reactive lymphadenopathy on FDG PET/CT after the third booster dose.

KW - Covid 19

KW - booster

KW - lymphadenopathy

KW - mRNA

KW - vaccination

KW - vaccine

UR - https://www.scopus.com/pages/publications/85126129071

UR - https://www.scopus.com/pages/publications/85126129071#tab=citedBy

U2 - 10.1016/j.cpccr.2021.100127

DO - 10.1016/j.cpccr.2021.100127

M3 - Article

C2 - 34746900

AN - SCOPUS:85126129071

SN - 2666-6219

VL - 4

JO - Current Problems in Cancer: Case Reports

JF - Current Problems in Cancer: Case Reports

M1 - 100127

ER -

Lymphadenopathy after the third Covid-19 vaccine

Abstract

Bibliographical note

UN SDGs

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this